EverydayHealthLogo
Dr. Julie Parsonnet, MD

Dr. Julie Parsonnet, MD

Stanford, CA

36 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Parsonnet, Infectious Disease Specialist in Stanford, CA?

    Dr. Julie Parsonnet, MD is an Infectious Disease Specialist, who primarily practices in Stanford, CA with 1 additional practice location. She has been practicing for over 36 years and is board certified by the American Board of Internal Medicine. Dr. Parsonnet graduated from Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University and completed her residency at Mass Gen Hosp, Internal Medicine. Dr. Parsonnet is fluent in English, French, and Spanish, and is currently seeing new patients. Dr. Parsonnet’s practice accepts Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Parsonnet’s office at (650) 723-4000.

    Where did Dr. Parsonnet go to medical school and complete their residency?

    • Fellowship: Massachusetts General Hospital MA | Massachusetts General Hospital

    • Residency: Mass Gen Hosp, Internal Medicine | Massachusetts General Hospital

    • Medical School: Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University

    Is Dr. Parsonnet board certified in Infectious Disease Specialist?

    Yes, Dr. Julie Parsonnet, MD is board certified by the American Board of Internal Medicine since 1986, American Board of Internal Medicine since 1988

    What languages does Dr. Parsonnet speak?

    Dr. Parsonnet and their clinical team can communicate with patients in the following languages:

    • English

    • French

    • Spanish

    What conditions does Dr. Parsonnet treat?

    As a Infectious Disease Specialist, Dr. Parsonnet diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Parsonnet. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Latent Tuberculosis
    • Lung Tuberculosis
    • Respiratory Tuberculosis
    • Tuberculosis
    • Inactive TB
    • Latent TB Infection
    • Hidden TB
    • Pulmonary Tuberculosis
    • TB of the Lungs
    • Consumption
    • Lung TB

    ICD-10 Codes:

    • Z227: Latent tuberculosis
    • A150: Tuberculosis of lung
    • A159: Respiratory tuberculosis unspecified

    Also known as:

    • Urinary Tract Infection
    • UTI
    • Bladder infection
    • Kidney infection
    • Urine infection

    ICD-10 Codes:

    • N390: Urinary tract infection, site not specified

    Also known as:

    • Valley Fever Meningitis
    • Widespread Valley Fever
    • Valley Fever
    • Meningitis
    • Fungal meningitis (Valley Fever)
    • Coccidioidal meningitis
    • Brain infection from Valley Fever
    • Systemic coccidioidomycosis
    • Valley Fever spread throughout body
    • Severe desert rheumatism
    • Coccidioidomycosis
    • Desert Fever
    • San Joaquin Fever

    ICD-10 Codes:

    • B384: Coccidioidomycosis meningitis
    • B387: Disseminated coccidioidomycosis
    • B389: Coccidioidomycosis, unspecified

    Also known as:

    • Abnormal Tuberculosis Blood Test Result
    • Positive TB Blood Test
    • Interferon Gamma Release Assay Reaction
    • IGRA Positive

    ICD-10 Codes:

    • R7612: Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis

    Also known as:

    • Blood Infection
    • Sepsis
    • Bacteremia
    • Bacteria in blood
    • Bloodstream infection

    ICD-10 Codes:

    • R7881: Bacteremia

    Also known as:

    • Lung Mycobacterial Infection
    • Other Mycobacterial Infection
    • Mycobacterial Infection
    • Pulmonary NTM Infection
    • Lung Nontuberculous Mycobacteria
    • Atypical Mycobacterial Infection
    • NTM Infection

    ICD-10 Codes:

    • A310: Pulmonary mycobacterial infection
    • A318: Other mycobacterial infections

    Also known as:

    • Bone Infection
    • Osteomyelitis
    • Infected Bone
    • Bone Inflammation
    • Bone Infection Disease

    ICD-10 Codes:

    • M869: Osteomyelitis, unspecified

    Also known as:

    • Fever
    • High temperature
    • Pyrexia
    • Elevated body temperature

    ICD-10 Codes:

    • R509: Fever, unspecified

    Also known as:

    • Lung Aspergillosis
    • Aspergillosis
    • Pulmonary Aspergillosis
    • Aspergillus Lung Infection
    • Aspergillosis in Lungs

    ICD-10 Codes:

    • B441: Other pulmonary aspergillosis

    Also known as:

    • Cellulitis
    • Skin infection
    • Bacterial skin inflammation
    • Acute skin infection

    ICD-10 Codes:

    • L0390: Cellulitis, unspecified

    Also known as:

    • Widespread Abdominal Pain
    • Abdominal Pain
    • General stomach pain
    • Overall belly pain
    • Diffuse abdominal pain

    ICD-10 Codes:

    • R1084: Generalized abdominal pain

    Also known as:

    • Histoplasmosis
    • Cave disease', 'Ohio Valley disease', 'Spelunker's lung

    ICD-10 Codes:

    • B394: Histoplasmosis capsulati, unspecified

    Also known as:

    • Spinal Bone Infection
    • Bone Infection
    • Vertebral Osteomyelitis
    • Infected Spine Bone
    • Spine Infection

    ICD-10 Codes:

    • M4620: Osteomyelitis of vertebra, site unspecified

    Also known as:

    • Leprosy
    • Mycobacterial Infection
    • Hansen's Disease
    • Mycobacterium Leprae Infection

    ICD-10 Codes:

    • A309: Leprosy, unspecified

    Which procedures does Dr. Parsonnet perform as a Infectious Disease Specialist?

    Does Dr. Parsonnet accept my insurance?

    Dr. Parsonnet accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Parsonnet accept in Stanford, CA?

    Dr. Parsonnet in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Advantage

    • All Other Third Party

    • Blue Shield of California

    • Centene

    • Central California Alliance for Health

    • CVS Health (formerly Aetna)

    • Medicaid

    • Medicare

    • Other Health Care Provider

    • Santa Clara Family Health Plan

    View All Insurances

    Where is Dr. Parsonnet's office located?

    Dr. Julie Parsonnet's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 723-4000

    Get Directions

    Dr. Julie Parsonnet's Practice 2

    211 Quarry Rd

    Palo Alto, CA 94304

    Get Directions

    Recognitions

    Awards

    George DeForest Barnett Professorship, Stanford

    Stanford University

    Henry J. Kaiser Family Foundation Award for Excellence in Preclinical

    Stanford University

    Henry J. Kaiser Award for Innovation in Medical Education

    Member, American Society for Clinical Investigation

    Best Doctors (.)

    Publications

    Cultivation and Serological Characterization of a Human Theiler's

    JOURL OF VIROLOGY, 2010

    Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis

    PLOS ONE, 2010

    Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States

    JOURL OF INFECTIOUS DISEASES, 2009

    Identification of cardioviruses related to Theiler's murine encephalomyelitis virus

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008

    Gastroenteritis and transmission of Helicobacter pylori infection in households

    EMERGING INFECTIOUS DISEASES, 2006

    Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma

    JOURL OF INFECTIOUS DISEASES, 2005

    Fecal and oral shedding of Helicobacter pylori from healthy infected adults

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 1999

    HELICOBACTER-PYLORI INFECTION AND GASTRIC LYMPHOMA

    NEW ENGLAND JOURL OF MEDICINE, 1994

    HELICOBACTER-PYLORI INFECTION AND THE RISK OF GASTRIC-CARCINOMA

    NEW ENGLAND JOURL OF MEDICINE, 1991

    The immune response to tuberculosis infection in the setting of Helicobacter pylori

    Epidemiology and infection, 2013

    Decreasing Intestil Parasites in Recent Northern California Refugees

    AMERICAN JOURL OF TROPICAL MEDICINE AND HYGIENE, 2013

    Local epidemic history as a predictor of tuberculosis incidence

    INTERTIOL JOURL OF TUBERCULOSIS AND LUNG DISEASE, 2011

    The impact of mucosal infections on acquisition and progression of tuberculosis

    MUCOSAL IMMUNOLOGY, 2011

    Clinical Application

    CLINICAL INFECTIOUS DISEASES, 2011

    Effect of Helicobacter pylori Infection on Symptoms of G

    DIGESTIVE DISEASES AND SCIENCES, 2011

    Role of Bacteria in Oncogenesis

    CLINICAL MICROBIOLOGY REVIEWS, 2010

    Immediate Incubation Reduces Indetermite Results for QuantiFERON-TB Gold In-Tube Assay

    JOURL OF CLINICAL MICROBIOLOGY, 2010

    Encouraging Scholarship

    ACADEMIC MEDICINE, 2010

    Engaging Students in Dedicated Research and Scholarship During Medical School

    ACADEMIC MEDICINE, 2010

    Required vs. Elective Research and In-Depth Scholarship Programs in the Medical Student Curriculum

    ACADEMIC MEDICINE, 2010

    Helicobacter pylori and gastric adenocarcinoma

    CLINICAL MICROBIOLOGY AND INFECTION, 2009

    The complete genome of klassevirus - a novel picorvirus in pediatric stool

    VIROLOGY JOURL, 2009

    Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract

    BRITISH JOURL OF CANCER, 2009

    Estimating disease prevalence using census data

    EPIDEMIOLOGY AND INFECTION, 2008

    Helicobacter pylori infection and development of pancreatic cancer

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008

    Reproducibility of QuantiFERON-TB gold in-tube assay

    CLINICAL AND VACCINE IMMUNOLOGY, 2008

    Cerebral myiasis associated with angiosarcoma of the scalp: case report.

    Neurosurgery, 2007

    Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus

    AMERICAN JOURL OF GASTROENTEROLOGY, 2007

    Helicobacter pylori infection and gender: A meta-alysis of population-based prevalence surveys

    DIGESTIVE DISEASES AND SCIENCES, 2006

    Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral

    JOURL OF CLINICAL MICROBIOLOGY, 2006

    Concordance of Helicobacter pylori infection among children in extended-family homes

    EPIDEMIOLOGY AND INFECTION, 2006

    Investigation of mediastinitis due to coagulase-negative staphylococci after cardiothoracic surgery

    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006

    Associations of serologic markers of infection and inflammation with vascular disease events

    Clinical and experimental nephrology, 2006

    Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006

    Validation of the blood quininium resin test for assessing gastric hypochlorhydria

    DIGESTIVE DISEASES AND SCIENCES, 2006

    Clinician-discoverers - Marshall, Warren, and H-Pylori

    NEW ENGLAND JOURL OF MEDICINE, 2005

    Commentary: H. pylori infection in early life and the problem of imperfect tests

    INTERTIOL JOURL OF EPIDEMIOLOGY, 2005

    Cell proliferation and inflammation on biopsy samples with multifocal atrophic g

    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2005

    QuantiFERON (R)-TB predicts tuberculin skin test boosting in US foreign-born

    INTERTIOL JOURL OF TUBERCULOSIS AND LUNG DISEASE, 2005

    Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area

    AMERICAN JOURL OF EPIDEMIOLOGY, 2005

    Risk of intestil helminth and protozoan infection in a refugee population

    AMERICAN JOURL OF TROPICAL MEDICINE AND HYGIENE, 2005

    Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali

    MALARIA JOURL, 2005

    Household transmission of gastroenteritis

    EMERGING INFECTIOUS DISEASES, 2005

    Significance of transiently positive enzyme

    JOURL OF CLINICAL MICROBIOLOGY, 2005

    Helicobacter pylori and risk of gastroenteritis

    JOURL OF INFECTIOUS DISEASES, 2004

    Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons

    EMERGING INFECTIOUS DISEASES, 2004

    Bacterial infection and MALT lymphoma

    NEW ENGLAND JOURL OF MEDICINE, 2004

    Helicobacter pylori infection and gastric cancer - For want of more outcomes

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2004

    Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004

    tural acquisition of Helicobacter pylori infection in newborn rhesus Macaques

    JOURL OF CLINICAL MICROBIOLOGY, 2003

    What is the Helicobacter pylori global reinfection rate?

    Cadian jourl of gastroenterology = Jourl cadien de gastroenterologie, 2003

    C-reactive protein, Helicobacter pylori

    ANLS OF EPIDEMIOLOGY, 2003

    Variability in antibiotic prescribing patterns

    CHEST, 2003

    Helicobacter pylori in cathartic stools of subjects with

    JOURL OF MEDICAL MICROBIOLOGY, 2003

    No association between Helicobacter pylori

    EPIDEMIOLOGY AND INFECTION, 2003

    Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions

    HUMAN PATHOLOGY, 2003

    Growth slowing after acute Helicobacter pylori infection is age-dependent

    JOURL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002

    Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer

    AMERICAN JOURL OF GASTROENTEROLOGY, 2002

    [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori

    Gaceta médica de México, 2002

    Helicobacter pylori: Consensus and controversy

    CLINICAL INFECTIOUS DISEASES, 2002

    A modification of the quininium resin test for assessing gastric acidity

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002

    CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma

    CARCINOGENESIS, 2002

    Validation of Spanish Language Dyspepsia Questionire

    DIGESTIVE DISEASES AND SCIENCES, 2002

    Quantifying the population impact of a prophylactic Helicobacter pylori vaccine

    VACCINE, 2001

    Determition of the infectious dose of Helicobacter pylori during primary

    INFECTION AND IMMUNITY, 2001

    Acute Helicobacter pylori infection is followed by an increase

    Pediatrics, 2001

    Helicobacter pylori and risk for gastric adenocarcinoma.

    Semirs in gastrointestil disease, 2001

    Screening markers for chronic atrophic gastritis in Chiapas, Mexico

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001

    Gastric atrophy and extent of intestil metaplasia in a cohort of Helicobacter pylori

    HUMAN PATHOLOGY, 2001

    Is anything safe to eat?

    Current clinical topics in infectious diseases, 2001

    Histological classification of gastric adenocarcinoma for epidemiological research

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001

    Helicobacter pylori infection and gastric cancer

    GASTROENTEROLOGY, 2001

    Variability of serologic testing for H-pylori using US and Peruvian antigens

    GASTROENTEROLOGY, 2001

    Confirmatory serologic testing for acute toxoplasmosis

    Liesenfeld, O., Montoya, J. G., Tathineni, N. J., Davis, M., Brown, B., 2001

    A dymic transmission model for predicting trends in Helicobacter pylori

    EMERGING INFECTIOUS DISEASES, 2000

    When heredity is infectious

    GASTROENTEROLOGY, 2000

    Interobserver variability in application of the revised Sydney classification for gastritis

    HUMAN PATHOLOGY, 1999

    Helicobacter pylori vaccine development and use

    HELICOBACTER, 1999

    Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory

    McFarland, W., Gwanzura, L., Bassett, M. T., Machekano, R., Latif, A. , 1999

    Helicobacter pylori and gastric cancer

    HELICOBACTER, 1999

    Helicobacter pylori virulence and genetic geography

    SCIENCE, 1999

    Rhesus monkey (Macaca mulatta) model of Helicobacter pylori

    LABORATORY ANIMAL SCIENCE, 1999

    Patterns of health seeking behavior during episodes of childhood diarrhea

    SOCIAL SCIENCE & MEDICINE, 1999

    Microbes and Maligncy: Infection as a Cause of Human Cancer

    Parsonnet J(ed)

    Gastrin and colorectal cancer: A prospective study

    GASTROENTEROLOGY, 1998

    Helicobacter pylori: the size of the problem

    GUT, 1998

    Helicobacter pylori

    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1998

    Helicobacter pylori infection and uriry excretion of 8-hydroxy-2-deoxyguanosine

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998

    Advances in the prevention and magement of traveler's diarrhea.

    Current clinical topics in infectious diseases, 1998

    Risk for gastric lymphoma in persons with CagA(+) and CagA(-) Helicobacter pylori infection

    Witherell, H. L., Hansen, S., Jellum, E., Orentreich, N., Vogelman, J., 1997

    Molecular mechanisms for inflammation-promoted pathogenesis of cancer

    CANCER RESEARCH, 1997

    Uriry phytoestrogen levels in young women from a multiethnic population

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997

    Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults

    Parsonnet, J., Replogle, M., Yang, S. F., Hiatt, R., 1997

    Should we treat H. pylori infection to prevent gastric cancer?

    Gastroenterology, 1997

    Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

    GUT, 1997

    Association between prior cytomegalovirus infection

    NEW ENGLAND JOURL OF MEDICINE, 1997

    Helicobacter pylori in the stomach - A paradox unmasked

    NEW ENGLAND JOURL OF MEDICINE, 1996

    Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer

    LANCET, 1996

    Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori.

    Helicobacter, 1996

    Principles of screening and surveillance

    Parsonnet, J., Axon, A. T., 1996

    Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan

    INTERTIOL JOURL OF EPIDEMIOLOGY, 1996

    Bacterial infection as a cause of cancer

    ENVIRONMENTAL HEALTH PERSPECTIVES, 1995

    BIOLOGIC SEX AS A RISK FACTOR FOR HELICOBACTER-PYLORI INFECTION IN HEALTHY-YOUNG ADULTS

    AMERICAN JOURL OF EPIDEMIOLOGY, 1995

    FLAGELLAR SEROTYPES OF SALMONELLA-TYPHI IN INDONESIA - RELATIONSHIPS AMONG MOTILITY, INVASIVENESS

    JOURL OF INFECTIOUS DISEASES, 1995

    THE INCIDENCE OF HELICOBACTER-PYLORI INFECTION

    Parsonnet, J., 1995

    GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION

    WESTERN JOURL OF MEDICINE, 1994

    PARASITISM BY THE SLOW BACTERIUM HELICOBACTER

    JOURL OF CLINICAL INVESTIGATION, 1994

    THE EPIDEMIOLOGY OF TUBERCULOSIS IN SAN-FRANCISCO

    NEW ENGLAND JOURL OF MEDICINE, 1994

    H pylori and gastric cancer.

    Lancet, 1994

    AZATHIOPRINE HYPERSENSITIVITY MIMICKING SEPSIS IN A PATIENT WITH CROHNS-DISEASE

    CLINICAL INFECTIOUS DISEASES, 1993

    HELICOBACTER-PYLORI, PEPSINOGEN, AND RISK FOR GASTRIC ADENOCARCINOMA

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1993

    CHRONIC IDIOPATHIC DIARRHEA

    NEW ENGLAND JOURL OF MEDICINE, 1993

    ANOTHER CASE OF POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE

    ARCHIVES OF NEUROLOGY, 1993

    HELICOBACTER-PYLORI AND GASTRIC-CANCER

    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1993

    PARAQUAT POISONING IN SOUTHERN MEXICO - A REPORT OF 25 CASES

    ARCHIVES OF ENVIRONMENTAL HEALTH, 1993

    THE ASSOCIATION OF HELICOBACTER-PYLORI WITH GASTRIC

    CANCER, 1993

    Hemolytic uremic syndrome: clinical picture and bacterial connection.

    Current clinical topics in infectious diseases, 1993

    SALT INTAKE AND STOMACH-CANCER - SOME CONTRARY EVIDENCE

    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1992

    SYMPTOMS AND RISK-FACTORS OF HELICOBACTER-PYLORI INFECTION IN A COHORT OF EPIDEMIOLOGISTS

    GASTROENTEROLOGY, 1992

    POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE

    ARCHIVES OF NEUROLOGY, 1991

    HELICOBACTER-PYLORI INFECTION IN INTESTIL-TYPE AND DIFFUSE-TYPE GASTRIC ADENOCARCINOMAS

    JOURL OF THE TIOL CANCER INSTITUTE, 1991

    MOLECULAR EPIDEMIOLOGIC TECHNIQUES IN ALYSIS OF EPIDEMIC AND ENDEMIC SHIGELLA-DYSENTERIAE TYPE

    JOURL OF INFECTIOUS DISEASES, 1991

    MULTIFOCAL COLITIS ASSOCIATED WITH AN EPIDEMIC OF CHRONIC DIARRHEA

    GASTROENTEROLOGY, 1991

    ASSOCIATION OF HELICOBACTER

    AMERICAN JOURL OF MEDICINE, 1990

    Surveillance imaging during remission identifies a group of patients

    PEDIATRIC INFECTIOUS DISEASE JOURL, 1989

    SHIGELLA-DYSENTERIAE TYPE-1 INFECTIONS IN UNITED-STATES TRAVELERS TO MEXICO, 1988

    LANCET, 1989

    TRICHOSPORON-BEIGELII PERITONITIS

    SOUTHERN MEDICAL JOURL, 1989

    INTERTIOL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .1. RECOMMENDATIONS FOR IMMUNIZATION

    PEDIATRIC INFECTIOUS DISEASE JOURL, 1989

    CHRONIC DIARRHEA ASSOCIATED WITH DRINKING UNTREATED WATER

    ANLS OF INTERL MEDICINE, 1989

    SIMPLE MICROBIOLOGIC DETECTION OF CAMPYLOBACTER-PYLORI

    JOURL OF CLINICAL MICROBIOLOGY, 1988

    What is Dr. Parsonnet's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Parsonnet's National Provider Identifier (NPI) number is 1083771646.

    What common questions do patients ask about Dr. Parsonnet?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Parsonnet

    What is Dr. Julie Parsonnet's specialty?

    Dr. Parsonnet is a Infectious Disease Specialist near Stanford, CA.

    An internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine.

    Contact Dr. Parsonnet to book an appointment today.

    Is this Dr. Julie Parsonnet affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Parsonnet is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Infectious Disease Specialist?

    Explore Infectious Disease Specialist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Julie Parsonnet accepting new patients in Stanford, CA?

    Yes, Dr. Julie Parsonnet is accepting new patients at this time.

    Does Dr. Julie Parsonnet offer online booking?

    Please contact Dr. Parsonnet's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Julie Parsonnet?

    Please contact Dr. Parsonnet's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Julie Parsonnet have?

    Dr. Julie Parsonnet is certified by the American Board of Internal Medicine.

    Other Infectious Disease Specialist Near Stanford, CA

    JS

    Infectious Disease Specialist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    EK

    Infectious Disease Specialist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    EV

    Infectious Disease Specialist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists